Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
addison disease
MeSH D000224 - addison disease
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D000309:
Adrenal insufficiency
141 Companies
25 Drugs
$
Success rate
D001327:
Autoimmune diseases
1 Company
1 Drug
$
Success rate
D000224:
Addison disease
53 Companies
8 Drugs
$
Success rate
D000075262:
Familial hypoadrenocorticism
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
100
%
6/6
Phase 2
100
%
6/6
Phase 3
56
%
5/9
Approved:
2
Overall Success rate:
56%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Dexamethasone
AbbVie
Dexamethasone
Novartis
Dexamethasone
,
Tobramycin
UCB
Dexamethasone
Bausch Health Companies
Dexamethasone
,
Neomycin
,
Polymyxin b
,
Tobramycin
Merck & Co
Dexamethasone
,
Lidocaine
,
Neomycin
Allergan
Dexamethasone
Dr Reddys Laboratories
Ciprofloxacin
,
Dexamethasone
Sun Pharmaceutical Industries
Dexamethasone
1
2
3
4
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use